Spersadex Compa. 5mg/mL. Sterile eye drops. Solution
PDF Leaflet Revision Date: 16 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Acute purulent conjunctivitis and other eye inflammations.
Dosage (summary)
1 drop, 1 to 4 times daily into the lower eyelid.
Special Populations
- Infants under 2 years
Pregnancy & Breastfeeding
Safety in pregnancy not established; not recommended in breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Bactericidal antibiotics
- Anticholinergics
Contraindications
- Hypersensitivity
- Fresh herpes simplex
- Glaucoma
- Newborn infants
Common side effects
- Burning
- Stinging
- Blurred vision
- Cataract
- Glaucoma
Counselling Points
- Do not use with soft contact lenses
- Report visual disturbances
- Avoid driving until vision is clear
Serious warnings
- Prolonged use may cause glaucoma
- Monitor intraocular pressure
Important Disclaimer
The Spersadex Compa. 5mg/mL. Sterile eye drops. Solution professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
